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Strategies for expanding hematopoietic stem cells
(HSCs) include coculture with cells that recapitulate
their natural microenvironment, such as bone
marrow stromal stem/progenitor cells (BMSCs).
Plastic-adherent BMSCs may be insufficient to pre-
serve primitive HSCs. Here, we describe a method
of isolating and culturing human BMSCs as nonad-
herent mesenchymal spheres. Human mesen-
spheres were derived from CD45 CD31 CD71
CD146+ CD105+ nestin+ cells but could also be sim-
ply grown from fetal and adult BM CD45-enriched
cells. Human mesenspheres robustly differentiated
into mesenchymal lineages. In culture conditions
where they displayed a relatively undifferentiated
phenotype, with decreased adherence to plastic
and increased self-renewal, they promoted
enhanced expansion of cord blood CD34+ cells
through secreted soluble factors. Expanded HSCs
were serially transplantable in immunodeficient
mice and significantly increased long-term human
hematopoietic engraftment. These results pave the
way for culture techniques that preserve the self-
renewal of human BMSCs and their ability to support
functional HSCs.INTRODUCTION
Hematopoietic stem cell (HSC) transplantation is routinely per-
formed for lifesaving procedures in patients with hematologic
malignancies or inherited metabolic/immune disorders. Different
HSC sources, such as bone marrow (BM), peripheral blood, and
cord blood, are used for allogeneic transplantation. The use of
cord blood has recently been revived because of the scarcity
of suitable BMdonors and because cord blood is easily and non-1714 Cell Reports 3, 1714–1724, May 30, 2013 ª2013 The Authorsinvasively harvested, cryopreserved units are immediately avail-
able, and patients have a reduced risk of disease transmission
and increased immune tolerance. However, the limited number
of HSCs present in cord blood has restricted its use to low-
body-weight recipients, whose survival correlates with HSC
dose (Broxmeyer, 2011). Ex vivo expansion of cord blood
HSCs would increase the number of patients who would benefit
from this therapy and reduce their mortality risk. However, HSC
expansion in culture remains challenging mainly due to our
limited knowledge on the factors that drive HSC self-renewal.
In vivo, this hallmark property of stem cells is maintained and
regulated by a specific microenvironment referred to as ‘‘niche’’
(Schofield, 1978). Coculture of HSCs with stromal cells that
recreate their natural niche is one of the current strategies aimed
to expand cord blood HSCs. The cells that form the adult
mammalian HSC niche and their specific functions in HSC
maintenance are a subject of intense investigation (Mercier
et al., 2012). Candidate HSC niche cells include BM stromal
stem/progenitor cells (BMSCs; Me´ndez-Ferrer et al., 2010;
Omatsu et al., 2010; Sacchetti et al., 2007), which have been pro-
posed as a source of feeder cells for HSC culture. BMSCs are
still today retrospectively isolated from primary human BM sam-
ples based on their high adherence to plastic and cultured from
fibroblastic colony-forming units (CFU-F; Friedenstein et al.,
1970). BMSCs cultured under standard conditions can support
the ex vivo expansion of hematopoietic progenitors (Breems
et al., 1997; Harvey and Dzierzak, 2004; Sharma et al., 2011; Ver-
faillie, 1992) but may be insufficient to preserve HSCs. To guar-
antee HSC engraftment in current clinical trials, a nonexpanded
cord blood unit (or part of it) is being cotransplanted with an
expanded one. The results reported to date indicate that the
expanded cord blood unit initially contributes to hematopoiesis
but only the nonexpanded cord blood unit is engrafted in the
long term (de Lima et al., 2012), suggesting that cord blood
CD34+ cells that have expanded on BMSCs grown under stan-
dard conditions might not contain functional long-term HSCs.
Alternatively, the relatively lower quantity of T lymphocytes pre-
sent in the expanded unit might also compromise its engraftment
(Urbano-Ispizua et al., 2001).
Figure 1. Human BM CD45 CD105+ nestin+
Cells Can Form Mesenspheres in Culture
Characterization of human BM mesensphere-
forming cells.
(A–C) Coexpression of nestin and CD105/endoglin
in a subset of human BM cells. Immunohisto-
chemistry of healthy human BM biopsy showing
expression of (A) NESTIN (green), (B) CD105 (red),
and (C) composite image with nuclei counter-
stained with DAPI (blue).
(D–F) Human BM mesenspheres derived from
CD45 CD105+ cells.
(D and E) Representative flow diagrams showing
the expression of (D) CD45 in BM nucleated cells
and (E) CD105 in BM CD45 cells.
(F and G) Within human BM stroma, only CD105+
cells could form mesenspheres (F), each of which
yielded 175 ± 12 alkaline phosphatase+ (pink)
clonal adherent fibroblastic colonies (G).
(H–O) Multilineage differentiation of human BM
mesenspheres into (H and I) osteoblasts, (J and K)
adipocytes, and (L–O) chondrocytes. qPCR of
genes associatedwith (H) osteoblastic (RUNX2 and
BGLAP), (J) adipogenic (CFD and ADIPOQ) and (L)
chondrogenic (SOX9, COL2A1, and COL11A2) dif-
ferentiation is shown in human BM mesenspheres
(Mes) and their progeny cultured for 4 weeks in
differentiation media (Dif; n = 3–22). *p < 0.05; un-
paired two-tailed t test. Error bars indicate SEM.
(I, K, and M–O) Histological analyses show a fully
differentiated phenotype of (I) alizarin red+ osteo-
blasts, (K) oil red O+ adipocytes, and (M) Alcian
blue+ or (N and O) toluidine blue+ chondrocytes.
(O) Representative toluidine-blue-stained paraffin
section of a sphere.
See also Figure S1.Murine BMSCs can be isolated based on the expression of the
intermediate filament protein nestin. Murine nestin+ BMSCs can
form clonal mesenchymal spheres (mesenspheres) that are able
to self-renew and spontaneously differentiate into mesenchymal
lineages both in vitro and in vivo. In the mouse, nestin+ BMSCs
are required to maintain HSCs in the BM and a single murine
mesensphere is able to transfer hematopoietic activity to an
ectopic bone ossicle (Me´ndez-Ferrer et al., 2010). Subendothe-
lial nestin+ cells have been reported in human BM (Ferraro et al.,
2011). In this study, we aimed to characterize human BMSCs
that are able to form mesenspheres, and assess their ability to
support HSCs. Our results show that nestin+ BMSCs with prop-
erties similar to those previously characterized in the mouse are
present in human fetal and adult BM. When cultured and
expanded in conditions that preserve their immature phenotype
(i.e., as floating multipotent spheres), they can promote ex vivo
human umbilical cord blood HSC expansion, which may poten-
tially be of therapeutic use.
RESULTS
Human BM CD45 CD31 CD71 CD105+ CD146+ Cells
Can Form Mesenspheres
We previously reported that in the BM of Nestin-Gfp transgenic
mice (Mignone et al., 2004), CD45 GFP+ cells contained allCthe CFU-F and had the capacity to form multipotent and self-re-
newing mesenspheres that spontaneously gave rise to mesen-
chymal lineages (Me´ndez-Ferrer et al., 2010). Because nestin
is an intermediate filament protein with intracellular localization,
we sought to identify candidate cell surface markers that would
allow isolation of human BM nestin+ cells. The transforming
growth factor b (TGF-b) receptor III endoglin/CD105 is a glyco-
protein that is expressed on the cell surface of osteoprogenitor
cells (Aslan et al., 2006). We first examined endoglin expression
in the BM of Nestin-Gfp transgenic mice and found that within
CD45 CD31 Ter119 GFP+ cells, the CD105+ population dis-
played a higher sphere-forming efficiency as compared with
CD105 cells (Figures S1A–S1C). Immunohistochemical ana-
lyses of human BM biopsies also showed CD105 expression in
a subset of nestin+ cells (Figures 1A–1C, S1D, and S1E). There-
fore, we sorted human BM CD45 cells according to CD105
expression and found that CD45 CD105+, but not CD45
CD105 cells, generated spheres (Figures 1D and 1E) that
were mesenspheres, based on their high content of cells that
were able to generate clonal alkaline phosphatase+ fibroblastic
colonies (Figure 1G) and robust multilineage differentiation into
osteoblasts (Figures 1H and 1I), adipocytes (Figures 1J and
1K), and chondrocytes (Figures 1L–1O).
We characterized the immunophenotype of human BM mes-
ensphere-initiating cells. In the human BM, CD45 CD31ell Reports 3, 1714–1724, May 30, 2013 ª2013 The Authors 1715
Figure 2. Human BMMesenspheres Are Derived fromCD45CD31
CD71 CD105+ CD146+ Cells
(A and B) Immunophenotype of human BM mesensphere-forming cells.
Healthy human BM CD45 CD31 CD71 cells (A) were sorted according to
CD105 and CD146 expression into three populations (B).
(C–E) Frequency of (C) clonogenic fibroblastic colonies and (D and E) spheres
derived from human BM nonhematopoietic/endothelial/erythroid CD105+
CD146+, CD105+ CD146, and CD105 CD146 cells plated (C and D)
at clonal density or (E) by single-cell deposition. The frequency is related to BM
mononuclear cells after separation with the RosetteSep Kit (StemCell Tech-
nologies) (n = 3 donors; error bars indicate SEM).
(F–I) Representative examples of human BM mesenspheres obtained by
(F and G) single-cell deposition or (H and I) bulk culture at low density.
(J and K) Histology of H&E-stained paraffin sections of human BM mesen-
spheres.
Scale bars, 200 mm (F, G, and I), 500 mm (H), and 100 mm (J and K). See also
Figure S2.CD146+/low cells have been reported to contain all CFU-F (Sac-
chetti et al., 2007; Tormin et al., 2011). Hence, CD45 CD31
CD71 (nonhematopoietic/endothelial/erythroid) cells were
sorted according to CD146 and CD105 expression (Figures 2A,
2B, and S2), and compared in terms of their capacity to form clo-
nogenic fibroblastic colonies and mesenspheres at clonal den-1716 Cell Reports 3, 1714–1724, May 30, 2013 ª2013 The Authorssity. All clonogenic and sphere-forming capacities were
restricted to the CD105+ CD146+ subset, and CD105 CD146
and CD105+ CD146 cells did not generate any progeny. The
frequency of clonogenic fibroblastic colonies (3.4% ± 2.1%)
was close to the sphere-forming efficiency (5.9% ± 2.3%) ob-
tained from CD45 CD31 CD71 CD105+ CD146+ cells plated
at low density. Sphere-forming efficiency (12.8% ± 4.7%) was
doubled when CD45 CD31 CD71 CD105+ CD146+ cells
were plated by single-cell deposition (Figures 2C–2I). The
spheres showed a compact structure with a thick core contain-
ing fibroblastic-shaped cells embedded in a dense eosinophilic
extracellular matrix (Figures 2J and 2K).
We next addressed whether human mesenspheres could be
obtained from fetal BM and whether these specific culture con-
ditions could select for the growth of sphere-forming cells
without the need for multiple selection markers. Fetal human
BM mononuclear cells were immunomagnetically depleted of
CD45+ cells and plated in mesensphere medium. Numerous hu-
man primary spheres formed after 7–10 days in culture (Fig-
ure 3A) and expressed not onlyNESTIN but also high messenger
RNA (mRNA) levels of stem cell factor (KITL) and leptin receptor
(LEPR; Figure 3B), which was recently shown in the mouse to
mark KITL-producing BMSCs that critically support HSCs
(Ding et al., 2012). Fetal human BMmesenspheres were capable
of robustly differentiating into osteoblasts (Figures 3C and 3D),
adipocytes (Figures 3E and 3F), and chondrocytes (Figures 3G
and 3H), providing further proof of their BMSC origin.
These results indicate that culture conditions similar to those
previously optimized in the mouse (Me´ndez-Ferrer et al., 2010)
can promote the selective growth of human mesenspheres
from fetal and adult BM stromal (immunomagnetically enriched)
CD45 cells without the need for additional selection markers,
although, in the adult human BM, mesensphere-initiating cells
are highly enriched within the CD45 CD31 CD71 CD105+
CD146+ cell population.
Expansion of Undifferentiated Human BM
Mesenspheres
Adult human BM mesenspheres were grown and expanded
under two different culture conditions, i.e., in cytokine-enriched
medium containing either human serum (HS) or chicken embryo
extract (CEE, a culture supplement that stimulates stem cell
self-renewal; Stemple and Anderson, 1992). The CEE mesen-
spheres were relatively undifferentiated compared with the HS
mesenspheres, as shown by increased NESTIN expression and
reducedmRNA levels of genes required for osteoblastic and adi-
pocytic differentiation (Figure 4A). The spheres could be serially
expanded under both culture conditions, although the CEEmes-
enspheres generated more spheres over serial passages (Fig-
ure 4B; 550 versus 320 spheres at passage 3). In addition,
whereas the CEE mesenspheres remained in suspension and
morphologically identical over >2 months in culture (Figure 4C),
the HS spheres attached even to ultralow-adherence dishes
and disappeared in the long term as a result of cell outgrowth
from the spheres as an adherent monolayer (Figure 4D).
Expanded CEE mesensphere-forming cells maintained expres-
sion of CD105 and CD146 (17% of sphere-forming cells; Fig-
ure 4E) and did not express CD45, CD31, or CD71 (data not
Figure 3. Human Mesenspheres Can Be
Derived from Fetal BM
(A) Representative spheres from immunomagneti-
cally enriched fetal human BM CD45 cells.
(B) Fetal human BM mesenspheres express
NESTIN, stem cell factor (KITL), and leptin receptor
(LEPR) mRNA; qPCR, n = 3.
(C–H) Multilineage differentiation of fetal human
BM mesenspheres. Spheres were enzymatically
dissociated and cultured for 3 weeks in (C and D)
osteoblastic, (E and F) adipocytic, and (G and H)
chondrocytic differentiation media.
(C, E, and G) qPCR of genes associated with (C)
osteoblastic (osterix,SP7; osteoglycin,OGN; Runt-
related transcription factor 2,RUNX2; osteoactivin,
GPNMB; osteocalcin, BGLAP), (E) adipogenic
(peroxisome proliferator-activated receptor
gamma, PPARG; adipsin, CFD; adiponectin,
ADIPOQ), and (G) chondrogenic (sex determining
region Y-box 9, SOX9; collagen 11a2, COL11A2;
collagen 2a1, COL2A1) differentiation (n = 3). Error
bars in (B), (C), (E), and (G) indicate SEM.
(D, F, and H) Histological analyses showing a
differentiated phenotype of (D) alizarin red+ oste-
oblasts, (F) oil red O+ adipocytes, and (H) Alcian
blue+ chondrocytes. Scale bar, 100 mm.shown). After being digested and replated three times,more than
half of the CEEmesenspheres differentiated into osteoblasts and
adipocytes, and all of the spheres that were analyzed (n = 20)
differentiated into toluidine blue+ chondrocytes (data not shown),
indicating preservation of multipotency under these culture
conditions (Figure 4F). To test whether human mesenspheres
were capable of in vivomaintenance and hematopoietic support,
single primary spheres were allowed to attach onto phosphocal-
cic ceramic ossicles and then implanted subcutaneously in
immunodeficient mice, as previously described (Me´ndez-Ferrer
et al., 2010). Ossicles were harvested after 2 months and enzy-
matically digested, and the recovered cells were isolated by fluo-
rescence-activated cell sorting (FACS) according to expression
ofmCD45, hCD146, and hCD105, and subcultured at clonal den-
sity inmesensphere-formingmedium (FiguresS3A andS3B). The
sphere-forming efficiency of hCD105+/hCD146+ cells (21% ±
8%) was 80-fold higher than that of hCD105 hCD146 cells
(0.3% ± 0.2%) recovered from the ossicles (Figure S3C). Alto-
gether, these results indicate preserved multipotency and main-
tenance of human BMSCs grown as mesenspheres.
We performed a quantitative proteomics analysis of the super-
natants of CEE and HS spheres to identify the most abundantCell Reports 3, 1714–17proteins that were differentially produced
by human BMSCs under both conditions.
The quantified proteins were subjected to
a systems biology comparative analysis.
HS mesenspheres displayed higher
expression of proteins involved in meta-
bolic processes, gene expression and
translation, mitochondrial and nucleolar
function, and ribonucleoprotein complex
and actin cytoskeleton formation. Incontrast, CEE mesenspheres produced more proteins involved
in cell adhesion, collagen and basement membrane production,
extracellularmatrix-protein interaction, axonguidance, response
to hypoxia, wounding, and organic cyclic compound production
(Figure 4G). CEE mesenspheres also produced more proteins
involved in angiogenesis, secretory granule production, and
signal transduction, as well as more glycosylated and plasma in-
tegral proteins. Interestingly, HS sphere-derived secretome con-
tained more proteins involved in cell-cycle progression, whereas
CEE mesenspheres expressed more proteins involved in cell-
cycle arrest, suchas those involved inTGF-b signaling (Figure 4H;
Table S1). These results indicate that nonadherent human mes-
enspheres are qualitatively distinct but may change their pheno-
type upon adherence to plastic. When cultured in conditions that
reduce their attachment to the dish, they display reduced prolif-
eration and metabolic rate, but increased maintenance and pro-
duction of active molecules as compared with more-differenti-
ated BMSCs that exhibit increased adhesion to plastic.
Human BM Mesenspheres Support HSCs
Our previous studies indicated that undifferentiated nestin+
BMSCs have essential functions in the regulation of murine24, May 30, 2013 ª2013 The Authors 1717
Figure 4. Expansion of Self-Renewing Hu-
man BM Mesenspheres
(A) qPCR analyses of the expression of nestin
(NES) or differentiation markers (RUNX2 and CFD)
in human BM mesenspheres cultured with CEE
(red) or HS (black), normalized to GAPDH.
(B–F) In vitro self-renewal of human mesen-
spheres, showing the number of CEE (red) and HS
(black) BM spheres over three passages. *p < 0.05;
unpaired two-tailed t test; error bars indicate SEM.
(C and D) CEE mesenspheres (C) were preserved
over passages, in contrast to HS spheres (D),
which attached even to ultralow-adherence
plastic.
(E) Representative FACS histograms of CEE
mesenspheres expanded over four passages,
which remained CD105+ (red) and CD146+ (blue);
gray, control isotype staining.
(F) After three passages, 55% of mesenspheres
(11/20) differentiated into two or more mesen-
chymal lineages.
(G and H) Comparison of the secretome of CEE
andHSmesenspheres by quantitative proteomics.
The cumulative frequency distributions of stan-
dardized log2 ratios (Zq) of proteins grouped into
ontological categories from GO, KEGG, or
REACTOME databases show the coordinated in-
crease or decrease of proteins belonging to these
categories. Related ontological categories have
been conventionally distributed into two graphs to
facilitate viewing of the pathways enriched in CEE
(Zq > 0, right shift of sigmoidal curves) or HS
(Zq < 0, left shift of curves) spheres when
compared with the predicted cumulative normality
plot of the standardized variable at the protein level
for all proteins (black curves).
See also Figure S3 and Table S1.HSCs (Me´ndez-Ferrer et al., 2010). Therefore, we studied
whether culture conditions that better preserve BMSC self-
renewal could also enhance their support of HSCs. Coculture
of 100 fresh CEE mesenspheres with 2 3 105 cord-blood-
derived CD34+ cells did not exceed the cell expansion achieved
only with cytokines, but doubled the number of primitive hemato-
poietic progenitors, as measured using the long-term culture-
initiating cell assay (LTCIC; Figure S4A), suggesting that human
BM mesenspheres could sustain cord blood HSC self-renewal.
Indeed, the frequency of cord-blood-derived HSCs, defined as
CD34+ CD38 CD49f+ cells (Notta et al., 2011), was already
increased 3 days after coculture with human BM mesenspheres
(Figure S4B).
Immature Human BM Mesenspheres Expand
Multipotent and Long-TermEngraftingCord BloodHSCs
We directly compared the ability of undifferentiated (CEE) and
more-differentiated (HS) mesenspheres to expand functional
HSCs capable of engrafting into immunodeficient mice. Cord1718 Cell Reports 3, 1714–1724, May 30, 2013 ª2013 The Authorsblood CD34+ cells were cultured alone
with cytokines or in the presence of
expanded HS or CEE adult BM mesen-
spheres (Figure 5A). The HS and CEEmesenspheres respectively yielded a 6- and 40-fold expansion
of cord blood CD34+ cells as compared with the control medium
(Figures 5B, 5C, and S5A). The capacity of cultured human
CD34+ cells to contribute to hematopoiesis was tested by trans-
plantation into immunodeficient mice. Cord blood CD34+ cells
expanded in coculture with HS mesenspheres did not increase
the presence of human CD45/CD71+ hematopoietic cells in the
BM of NOD/SCID mice when compared with CD34+ cells
cultured only with cytokines. In contrast, cord blood CD34+ cells
expanded in coculture with CEEmesenspheres yielded a 38-fold
increase in BM human hematopoietic chimerism of NOD/SCID
mice 2 months later (average 6.1% engraftment; Figures 5D
and S5B). In addition, subcutaneous implantation of 23 106 co-
cultured hematopoietic cells did not generate teratomas in NOD/
SCID mice (data not shown).
We tested the self-renewal andmultilineage differentiation po-
tential of expanded HSCs by transplantation into NOD/SCID/
gamma (NSG) mice. Two months after transplantation into
NSG mice, cord blood CD34+ cells expanded in coculture with
Figure 5. Increased HSC Engraftment in
Immunodeficient Mice from Cord Blood
CD34+ Cells Cocultured with Primitive
Human BM Mesenspheres
(A) Cord blood CD34+ cells were cultured in serum-
free medium containing cytokines in the absence
(Alone, black) or presence of human BM mesen-
spheres previously expanded with HS (blue) or
CEE (red).
(B and C) HS and CEE mesenspheres previously
expanded over 4 weeks respectively yielded 6-
and 40-fold expansion of cord blood CD34+ cells
as compared with CD34+ cells cultured alone (A).
(C) Number of cord blood CD34+ cells measured
by FACS after 16 days of culture (n = 3).
(D–I) CEEmesenspheres can expand humanHSCs
that are capable of multilineage reconstitution and
serial engraftment in immunodeficient mice.
(D) Percentage of human CD45+/CD71+ cells in
the BM of NOD/SCID mice 2 months after
transplantation of 104 freshly thawed (F) cord
blood CD34+ cells or their progeny after 16 days
of culture with cytokine-supplemented serum-
free medium alone (A) or in the presence of
HS (+HS) or CEE (+CEE) spheres; n = 3;
*p < 0.05; unpaired two-tailed t test. Error bars
indicate SEM.
(E) Percentage of human CD45+ cells in the BM of
NSG mice 2 months after transplantation of the
progeny of nonfrozen 104 cord blood CD34+ cells
cultured for 2 weeks in cytokine-supplemented
serum-free medium alone (A) or in the presence of
CEE (+CEE) spheres.
(F) Representative FACS diagrams of hCD45-
stained BM cells from NSG mice transplanted with
CD34+ cells that were cultured alone (A) or in the
presence of CEE (+CEE) spheres.
(G and H) Multilineage differentiation of cord
blood CD34+ cells in NSG mice. Representative
FACS diagrams of BM cells 2 months after
transplantation of cultured cord blood CD34+
cells in NSG mice. BM cells were stained
with (G) anti-hCD45 (hematopoietic) and anti-hCD19 (B-lymphoid) or with (H) anti-hCD33 (myeloid) and anti-hCD235a/glycophorin A (erythroid) antibodies.
(I) Serial reconstitution of expanded cord blood CD34+ cells in NSG mice. Secondary transplant of BM cells harvested from mice that showed a similar hCD45
engraftment 2 months after transplantation of CD34+ cells that were cultured alone (A) or in the presence of CEE (+CEE) spheres.
(E and I) Following previous studies, engraftment was considered positive (red dots) whenR0.1% hCD45 cells were engrafted (gray dotted line) and negative
(black dots) below this threshold.
See also Figures S4 and S5, and Table S2.CEE mesenspheres yielded a 12.5-fold increase in human he-
matopoietic chimerism of NSG BM when compared with
CD34+ cells cultured only with cytokines. Although only 40% of
mice (2/5) transplanted with CD34+ cells cultured alone showed
human hematopoietic engraftment above the 0.1% threshold,
62.5% (5/8) showed engraftment of CD34+ cells that had been
cocultured with CEE mesenspheres (Figures 5E and 5F).
Expanded cord blood CD34+ cells contained functional HSCs
capable of accomplishing multilineage differentiation into
B-lymphoid (Figure 5G), myeloid, and erythroid cells (Figure 5H).
We tested the capacity of cultured HSCs to engraft into second-
ary recipient mice. BM cells from mice that showed a similar
hCD45 engraftment after transplantation of CD34+ cells cultured
alone or in the presence of CEE spheres were used for second-
ary transplants. The BM engraftment of hCD45+ cells 2 monthsCafter secondary transplantation demonstrates that expanded
cord blood CD34+ cells that yielded a similar engraftment in pri-
mary recipients were equally able to reconstitute secondary
recipient mice (Figure 5I).
Human BM Mesenspheres Expand Long-Term Cord
Blood HSCs through Soluble Secreted Factors
Although some studies have suggested that cell contact be-
tween BMSCs and hematopoietic progenitors is required to
expand the latter (Harvey and Dzierzak, 2004; Kawada et al.,
1999; Thiemann et al., 1998), other studies have shown an effect
that is largely independent of direct cell contact (Breems et al.,
1997; Verfaillie, 1992). We tested the capacity of expanded hu-
man mesenspheres to support cord blood CD34+ cells in direct
coculture or separated by transwell. A similar expansion of cordell Reports 3, 1714–1724, May 30, 2013 ª2013 The Authors 1719
Figure 6. Human BM Mesenspheres Sup-
port Cord Blood HSCs Mainly through
Secreted Factors
(A–C) Cord blood CD34+ cells were cultured for
16 days in serum-free medium containing cyto-
kines (A) in the absence of or (B and C) in coculture
with human fetal mesenspheres, either (B) in direct
contact or (C) separated by transwell.
(D) Growth curve of cord blood CD34-enriched
cells cultured alone (black line), in contact with
humanmesenspheres (blue line) or separated from
them by transwell (red line).
(E) Number of CD34+ cells measured by FACS
(n = 3; error bars indicate SEM).
(F–H) Soluble secreted factors produced by
human BM mesenspheres expand cord blood
HSCs capable of long-term reconstitution and
multilineage differentiation in immunodeficient
mice.
(F) Percentage of human CD45+ cells in the BM of
NSG mice 16 weeks after transplantation of cord
blood CD34+ cells cultured for 3 weeks with
human BM mesenspheres in direct contact or
separated by transwell. *p < 0.05; unpaired two-
tailed t test.
(G) Representative FACS diagrams of hCD45-
stained BM cells from NSG mice 4 months after
transplantation of CD34+ cells cultured in both
conditions.
(H) Representative FACS diagram showing long-
term multilineage reconstitution. BM cells were
stained with anti-hCD45 (hematopoietic), anti-
hCD19 (B-lymphoid), and anti-hCD33 (myeloid)
antibodies.
(I) Protein-protein interactions predicted from
the list of proteins detected in the secretome
of human CEE BM mesenspheres (n = 3 inde-
pendent donors). Only proteins for which two
or more peptides were detected in two or
more samples were considered for the analyses using STRING 9.0. Interactions were identified from experimental data and databases using a high
confidence level (0.700). The clustering was performed using the MCL algorithm (inflation parameter set at 2).
(J) Enrichment in relevant canonical pathways detected using Ingenuity Pathway Analysis.
See also Figures S4 and S5.blood CD34+ cells was detected in the direct and transwell co-
cultures with CEE mesenspheres (Figures 6A–6E), suggesting
that soluble factors secreted by the spheres might be sufficient
to promote HSC expansion. We compared the direct and trans-
well cocultures in terms of their capacity to expand cord blood
HSCs with long-term engraftment in immunodeficient mice.
Cord blood CD34+ cells that had been cocultured for 3 weeks
with humanmesenspheres, either directly or separated by trans-
well, were i.v. transplanted into NSG mice. Strikingly, a 4-fold
higher human hematopoietic chimerism was detected 16 weeks
later in the BM of mice transplanted with cord blood cells that
had been cocultured using transwell as compared with direct
coculture. Notably, human chimerism was >20% in 50% of
mice from the transwell group (Figures 6F and 6G). Long-term
engraftment from cocultured cord blood HSCs was also associ-
ated with multilineage reconstitution (Figure 6H). These results
indicated that soluble factors secreted from human BM mesen-
spheres are responsible for HSC expansion. Therefore, we per-
formed high-throughput mass spectrometry analyses of proteins1720 Cell Reports 3, 1714–1724, May 30, 2013 ª2013 The Authorssecreted by CEE human mesenspheres to better characterize
CEE-mesensphere-forming cells and candidate HSC-support-
ing factors. These analyses identified >1,100 proteins in three
independent samples. Potentially secreted proteins were
determined and quantitated as previously described (Bonzon-
Kulichenko et al., 2011). Proteins of the TGF-b pathway that,
similarly to some of their target genes (e.g., osteopontin), have
been reported to induce HSC quiescence (Larsson and Karls-
son, 2005; Nilsson et al., 2005; Stier et al., 2005) were also de-
tected. Growth factors such as hepatocyte, basic fibroblastic
and connective tissue growth factors, and other molecules that
have been shown to support HSCs, such as insulin-like growth
factor (IGF), angiopoietin-like growth factor (Zhang et al.,
2008), and prostaglandin-related proteins (Goessling et al.,
2011; Hoggatt et al., 2009; North et al., 2007), were also detected
and may represent other candidate factors that support HSCs.
The most abundant secreted proteins were those involved in
basement membrane and extracellular matrix formation, such
as collagens, laminins, fibronectin, proteoglycans, nidogens,
and matrix metalloproteinases. Integrins and other related pro-
teins, such as vinculin and talin, were also abundant. Different
calcium transport and metabolism proteins, as well as neural
guidance/outgrowth and norepinephrine catabolism proteins,
were also detected. The BMSC markers found in these samples
included endoglin, CD90, CD276, VCAM-1, CD44, and CD151.
Filament proteins associated with nestin, such as vimentin, des-
min, plectin, and filamin-A, were abundant in these samples (Fig-
ures 6I and 6J; Table S2). These results show that human BM
mesenspheres secrete many different proteins that are able to
affect HSC function, and suggest that most likely multiple factors
secreted by them contribute to maintain HSCs in culture.
In summary, this study demonstrates that BMSCs with fea-
tures similar to those previously characterized in the mouse
(Me´ndez-Ferrer et al., 2010) are present in human fetal and adult
BM. When expanded in novel nonadherent conditions that pre-
serve their immature phenotype, they can promote ex vivo
HSC self-renewal and expansion, which may potentially be of
therapeutic use.
DISCUSSION
We describe here a method of isolating and culturing human
BMSCs in a way that better preserves their self-renewal and
HSC niche functions. Over the past few years, different strate-
gies have been used for ex vivo expansion of HSCs, especially
those derived from cord blood. These include treatments with
angiopoietin-like proteins, IGF-binding protein 2 (Zhang et al.,
2008), the Notch ligand Delta1 (Delaney et al., 2010), antagonists
of the aryl hydrocarbon receptor (Boitano et al., 2010), dimethyl-
prostaglandin E2 (Goessling et al., 2011; Hoggatt et al., 2009;
North et al., 2007), and inhibitors of apoptotic proteases (San-
geetha et al., 2010). BM engraftment of cord blood HSCs is
also accelerated after inhibition of CD26/dipeptidylpeptidase IV
(Campbell et al., 2007; Christopherson et al., 2007) and ex vivo
fucosylation (Robinson et al., 2012).
BMSCs cultured under standard adherent conditions have
been shown to support the ex vivo expansion of hematopoietic
progenitors (Breems et al., 1997; Harvey and Dzierzak, 2004;
Sharmaet al., 2011; Verfaillie, 1992) butmaybe insufficient topre-
serve primitive HSCs (de Lima et al., 2012). However, BMSCs are
still retrospectively isolated based on their high plastic adherence
and/or cultured in minimal medium supplemented with serum.
We previously showed that self-renewing murine mesen-
spheres are able to transfer hematopoietic activity to an engi-
neered bone scaffold (Me´ndez-Ferrer et al., 2010). In the current
study, we characterized a human BM cell population that was
able to form mesenspheres, and assessed its capacity to sup-
port cord blood HSCs. Our results demonstrate that nestin+
BMSCs with properties similar to those previously characterized
in themouse are present in human fetal and adult BM.We did not
need to use specific surface markers to grow human mesen-
spheres, because we could simply derive them from immuno-
magnetically enriched CD45 cells using a specific culture
medium. Like colony-initiating cells (CFU-F), mesensphere-
forming cells were highly enriched in the CD45 CD31 CD71
CD105+ CD146+ population. A subset of the cells contained in
the spheres remained CD105+ and CD146+ over passages.CAlthough only a small number of primary mesenspheres could
be obtained fromhumanBMaspirates, they could be propagated
over 2 months during multiple divisions. Notably, spheres
cultured with CEE showed increased in vitro self-renewal as
compared with those cultured with HS. Moreover, the presence
of HS instead of CEE in themedium led to reduced nestin expres-
sion, upregulation of differentiationmarkers, and cell attachment,
even to ultralow-adherent plastic. In agreement with this, other
studies have suggested that nonadherent human BM mesen-
chymal progenitors display a higher differentiation potential
(Bakshet al., 2003) andcannotbemaintainedwithserum(DiMag-
gio et al., 2012). These changes were associated with a marked
difference in HSC support. Although coculture with HS spheres
increased the cord blood CD34+ cell yield, only CEE spheres
could increase the engraftment in immunodeficient mice.
Notably, cord blood HSC expansion was triggered by soluble
secreted factors produced by CEE mesenspheres. Although
some studies have suggested that cell contact between BMSCs
and hematopoietic progenitors is required to expand the latter
(Harvey and Dzierzak, 2004; Kawada et al., 1999; Thiemann
et al., 1998), other studies have suggested that direct cell-cell
interaction is not required (Breems et al., 1997; Verfaillie,
1992). Our results support the last contention, since a 4-fold
higher long-term reconstitution was detected from cord blood
cells cocultured with human mesenspheres that were separated
by transwell. This was also associated with a higher recovery of
mesenspheres cocultured on the transwell compared with those
directly cocultured using ultralow-adherent plastic dishes (data
not shown). Since the coculture medium in all cases was a he-
matopoietic-supporting medium rather than amesensphere me-
dium, these differences suggest that the mere attachment of the
spheres to the plastic dish during the direct coculture changed
their phenotype and impaired their ability to secrete factors
capable of expanding HSCs.
Candidate factors that were abundantly produced by CEE
spheres and could contribute to HSC expansion include proteins
of the TGF-b pathway that have been reported to preserve HSC
quiescence (Larsson and Karlsson, 2005; Nilsson et al., 2005;
Stier et al., 2005); hepatocyte, basic fibroblastic and connective
tissue growth factors, IGF, and angiopoietin-like growth factor
(Zhang et al., 2008); and prostaglandin-related proteins (Goes-
sling et al., 2011; Hoggatt et al., 2009; North et al., 2007). There-
fore, multiple factors could contribute to the enhanced HSC sup-
port displayed by CEE mesenspheres. Elucidation of critical
mediators in the future might facilitate the optimization of chem-
ically defined media for human HSC expansion. The ability to
expand cord blood HSCs in transwell coculture with human
mesenspheres might increase their safety in humans and facili-
tate testing of their potential clinical benefit. In addition, cells
that expanded under these conditions did not generate tera-
tomas in immunodeficient mice.
In summary, these results demonstrate that primitive nestin+
BMSCs are present in human fetal and adult BM. Without the
need for complex isolation protocols, they can give rise to self-
renewing mesenspheres with a more primitive phenotype and
enhanced ex vivo HSC support as compared withmore-differen-
tiated BMSCs. These studies pave the way for new isolation and
culture strategies to better preserve the self-renewal of humanell Reports 3, 1714–1724, May 30, 2013 ª2013 The Authors 1721
BMSCs and their ability to support HSCs, which will critically
determine the success of these approaches in the clinical arena.
EXPERIMENTAL PROCEDURES
Mouse Strains
NOD.CB17-Prkdcscid/J, NOD/LtSz-scidIL2Rgnull (Jackson Laboratories) and
Nestin-Gfp (Mignone et al., 2004) transgenic mice were used in these studies.
Experimental procedures were approved by the Animal Care andUseCommit-
tee of the Spanish National Center for Cardiovascular Research.
Cell Isolation and Culture
BM aspirates were obtained in the Hospital Clı´nic (University of Barcelona,
Spain) and Ska˚ne University Hospital (Lund, Sweden) with written consent
from healthy individuals, donors of BM hematopoietic progenitor cells for allo-
geneic transplantation or patients free of hematological diseases. The samples
obtained were processed in two different ways. For sorting experiments,
human BM mononuclear cells were enriched from 60 ml human BM aspirates
using the RosetteSep kit (StemCell Technologies). Cells were stained with
7-Aminoactinomycin D (7AAD) solution (Sigma) and the following mouse
anti-human antibodies (BD PharMingen): CD31-FITC (clone WM59), CD45-
FITC (clone 2D1), CD71-FITC (clone M-A712), CD105-APC (clone 266), and
CD146-PE (clone P1H12). 7AAD CD45 CD31 CD71 cells were isolated
according to CD105 and CD146 expression into CD105+ CD146+, CD105+
CD146 and CD105 CD146 cells. For other experiments, the filters used
to trap bone spicules and cell aggregates were carefully and aseptically
washed with cold PBS several times. Cells were recovered by centrifugation
and erythrocytes were lysedwith 0.8%NH4Cl. After a wash and centrifugation,
the pellet was enzymatically dissociated in a solution containing 0.25% type I
collagenase and 20% fetal bovine serum (FBS) in PBS (StemCell Technolo-
gies) for 30 min at 37C, with mechanical agitation every 10 min.
Human fetal BM samples were obtained from Leiden University Medical
Center (The Netherlands) under a protocol approved by the ethics committee
of that institution. Fetal BM samples were mechanically dispersed and the
mononuclear cells were isolated by Ficoll gradient, frozen, and kept in liquid
nitrogen. Cells were thawed, washed with PBS once, and stained with anti-
bodies for immunomagnetic enrichment using anti-CD45 magnetic beads
(Miltenyi Biotec) according to the manufacturer’s recommendations.
For sphere formation, sorted cells were plated at low density (<1,000
cells/cm2) or by single-cell deposition in ultralow-adherence 35 mm dishes
(StemCell Technologies). The growth medium for both CEE and HS spheres
contained 0.1 mM b-mercaptoethanol; 1% nonessential amino acids (Sigma);
1% N2 and 2% B27 supplements (Invitrogen); recombinant human fibroblast
growth factor (FGF)-basic, recombinant human epidermal growth factor
(EGF), recombinant human platelet-derived growth factor (PDGF-AB), recom-
binant human oncostatin M (227 aa OSM, 20 ng/ml) and recombinant human
IGF-1 (40 ng/ml; Peprotech) in Dulbecco’s modified Eagle’s medium (DMEM)/
F12 (1:1) / human endothelial (1:2) serum-free medium (Invitrogen). CEE
medium was supplemented with 15% CEE prepared as described previously
(Pajtler et al., 2010; Stemple and Anderson, 1992), and HS medium was
instead supplemented with 10% HS. The cultures were kept at 37C with
5% CO2, 20% O2 in a water-jacketed incubator and left untouched for
1 week to prevent cell aggregation. Afterward, half-medium changes were
performed twice a week. For passage, spheres were enzymatically dissoci-
ated in 100 ml of a solution containing 0.25% type I collagenase and 20%
FBS in PBS (StemCell Technologies) for 30 min at 37C, with mechanical
dispersion every 10 min. Cells were washed with PBS once and replated
with mesensphere medium in ultralow-adherence 35 mm dishes (StemCell
Technologies) at 37C in awater-jacketed incubator with 5%CO2 and 20%O2.
Human CD34+ cells pooled from cord blood samples were purchased
(StemCell Technologies) or isolated as follows: Cord blood samples were ob-
tained in accordance with procedures approved by the institutional ethics
committee. Two to three cord blood units were pooled and erythrocytes
were removed by Ficoll-Paque density gradient centrifugation. CD34+ cells
were isolated by magnetic cell selection using anti-hCD34 magnetic microbe-
ads (Miltenyi) and frozen immediately after purification. Cord blood CD34+1722 Cell Reports 3, 1714–1724, May 30, 2013 ª2013 The Authorscells were cultured as previously described (Zhang et al., 2006) in StemSpan
serum-free medium (StemCell Technologies) supplemented with 10 mg/ml
heparin (Sigma), recombinant human stem cell factor, recombinant human
FGF-1 (10 ng/ml), recombinant human thrombopoietin (20 ng/ml; Peprotech),
and 1% penicillin-streptomycin (Invitrogen) at 37C in a water-jacketed incu-
bator with 5% CO2. Culture dishes were diluted 1:1 with fresh medium two
to three times a week to maintain cell density. Spheres were directly added
to the culture dishes or placed in the upper chamber of a 0.2 mm pore polycar-
bonate transwell (Corning) in the samemedium. Spheres were cocultured with
CD34+ cells at a starting ratio of 1:1,000.
Immunostaining and Histology
Human BM biopsies were obtained in the Clı´nic Hospital (Barcelona, Spain)
from healthy donors with their written consent. The biopsy specimens were
embedded in paraffin, sectioned with a microtome, and mounted onto slides.
After deparaffinization with xylol, the sections were rehydrated and washed
with PBS. Sections were washed and blocked with blocking buffer (PBS
with 0.1% Triton X-100, 10% donkey serum) for 30 min and incubated over-
night at 4C with primary antibodies in blocking buffer (rabbit anti-human Nes-
tin [Millipore 1:200], goat anti-human endoglin [R&D 1:20] or control rabbit or
goat immunoglobulin G [IgG] at the same concentrations). The samples
were washed in PBS several times and incubated with species-specific fluo-
rescent secondary antibodies (Alexa 488-conjugated donkey anti-rabbit IgG
[Invitrogen] and Cy3-conjugated donkey anti-goat IgG [Jackson Labora-
tories]). The samples were then washed in PBS with 0.1% Triton X-100 and
mounted (Vectashield fluorescent mounting medium with DAPI; Vector
Labs). Images were captured using a confocal microscope (Sp5; Leica) with
acquisition software (LAS AF; Leica). For histological analysis, human mesen-
spheres were fixed in suspension with 2% paraformaldehyde in PBS and
embedded in paraffin for sectioning. Microtome sections were processed
with routine hematoxylin and eosin (H&E) staining and images were acquired
using a Zeiss Axiovert 200 microscope.
In Vitro Differentiation
Osteoblastic differentiation was induced by culturing the cells for 4 weeks with
50 mg/ml L-ascorbic acid 2-phosphate, 10mMglycerophosphate (Sigma), and
15% FBS in a-MEM with 1% penicillin-streptomycin (Invitrogen). Adipocyte
differentiation was induced with 1 mM dexamethasone, 10 mg/ml insulin
(Sigma), and 10% FBS in a-MEM with 1% penicillin-streptomycin (Invitrogen).
Chondrogenic differentiation was induced in cell pellets with 107 M dexa-
methasone, 104 M L-ascorbic acid 2-phosphate, 1 mM sodium pyruvate,
nonessential amino acids, 13 SITE+3 supplement (1 mg/ml human insulin,
0.55 mg/ml human transferrin, 0.5 mg/ml sodium selenite, 0.2 mg/ml ethanol-
amine, 470 mg/ml linoleic acid, 470 mg/ml oleic acid, and 50 mg/ml bovine
serum albumin; Sigma) and 10 ng/ml TGF-b3 (Peprotech) in DMEM with 1%
penicillin-streptomycin (Invitrogen) over 2–4 weeks. All cultures were main-
tained with 5% CO2 in a water-jacketed incubator at 37
C, and half-medium
changes were performed twice a week. To assess in vitro differentiation into
mesenchymal lineages, cells were briefly washed with PBS and fixed for
10min with 2%paraformaldehyde in PBS (Sigma). For the detection of alkaline
phosphatase activity, cells were washed twice with PBS and incubated for
20 min at room temperature with 50 mg/ml Naphthol AS-MX phosphate,
0.5% N,N-Dimethylformamide, and 0.6 mg/ml Fast Red Violet LB in 0.1 M
Tris-HCl, pH 8.9. Alizarin red staining of calcium deposits was performed in
fixed cultures washed with distilled water and incubated with 2% alizarin red
for 5 min, followed by washes in distilled water. Adipocytes were stained
with oil red O as follows: cells were washed with 60% isopropanol and allowed
to dry completely. An oil red working solution was prepared as a 6:4 dilution in
distilled water of a 0.35 g/ml oil red O solution in isopropanol (Sigma) and
filtered 20 min later. Cells were incubated for 10 min with oil red working solu-
tion and rinsed 4 times. To stain mucopolysaccharides associated with chon-
drocytic differentiation, fixed cultures and cell pellets were incubated for
30 min at room temperature with 1% Alcian blue 8GX (Sigma) in 3% acetic
acid, pH 2.5, and rinsed four times. For toluidine blue staining of chondrocytes,
fixed spheres or their rehydrated paraffin sections were incubated in 1% tolu-
idine blue (Amresco) in 1% sodium tetraborate decahydrate (Sigma) for 5 or
2 min, respectively, and washed afterward.
RNA Isolation and Real-Time Quantitative RT-PCR
RNA isolation was performed using the Dynabeads mRNA DIRECT Micro Kit
(Invitrogen). RT was performed using the Reverse Transcription System
(Promega) according to the manufacturer’s recommendations. Real-time
quantitative RT-PCR (qRT-PCR) was performed as previously described
(Me´ndez-Ferrer et al., 2008). The expression level of each gene was deter-
mined by using the relative standard curve method. Briefly, a standard curve
was obtained by serial dilutions of a human reference total RNA (Clontech).
The expression level of each gene was calculated by interpolation from the
standard curve. All values were normalized with glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) as the endogenous control. The sequences of the
oligonucleotides used for PCR are provided in Table S3.
In Vivo Transplantation and Hematopoietic Human Chimerism in
Immunodeficient Mice
Freshly thawed 104 cord blood CD34+ cells or their cultured progeny were
washed and resuspended in 100 ml PBS and i.v. injected, retro-orbitally or
through the tail vein, into immunodeficient mice previously anesthetized with
sevoflurane. Two months after transplantation, the femora was crushed in
cold PBS and the BM was harvested and analyzed by FACS (without lysing
red blood cells) to detect the presence of human hematopoietic cells in the
BM of the recipient mice.
In Vivo Transplantation of Human Mesenspheres in Subcutaneous
Ossicles in Immunodeficient Mice
Ceramic porous cubes (3 mm3) composed of 65% calcium phosphate hy-
droxyapatite and 35% tricalcium phosphate (Ceraform) were washed with
distilled water twice to discard small detached fragments, autoclaved, and
coated with 0.1 mg/ml fibronectin from bovine plasma (Sigma). To eliminate
the air contained in the cubes and ensure proper coating of the pores, the os-
sicles were placed in a FACS tube containing the fibronectin solution and
agitated for 1 min while negative pressure was applied by suction with a
60 ml syringe and a 21 gauge needle through the tube cap. The cap was re-
placed by a new one and the procedure was repeated once. Fibronectin-
coated ossicles were allowed to dry overnight in a laminar flow hood. Single
human mesenspheres were gently deposited onto the ossicles and allowed
to attach for 24 hr in the incubator. The ossicles were implanted s.c. under
the dorsal skin of 6- to 12-week-old anesthetized recipient NOD/SCID mice.
Two months later, the ossicles were harvested and enzymatically dissociated
in a solution containing 0.25% type I collagenase and 20% FBS in PBS
(StemCell Technologies) for 60 min at 37C, with mechanical agitation every
10 min. The recovered cells were analyzed by FACS.
Detailed methods for the secretome proteomics are available in the
Extended Experimental Procedures.
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